Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide Autogel 120 mg in Newly Diagnosed Acromegaly
NCT00627796Phase 4Completed
- Sponsor
- University of Naples Federico II
- Start
- Jan 2003
- Primary completion
- Dec 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of lanreotide in acromegaly, sponsored by University of Naples Federico II. Started Jan 2003; status: completed.
02
Drugs
lanreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00627796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627796.